与攀登富士山相关的高原肺水肿
High Altitude Pulmonary Edema Associated with Climbing Mount Fuji.
作者信息
Fukuda Yosuke, Oda Naruhito, Izumizaki Kensuke, Tanaka Akihiko, Sagara Hironori
机构信息
Department of Medicine, Division of Respiratory Medicine, Yamanashi Red Cross Hospital, Japan.
Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Japan.
出版信息
Intern Med. 2025 Jul 15;64(14):2229-2233. doi: 10.2169/internalmedicine.4590-24. Epub 2025 Jan 3.
A 51-year-old man presented to the emergency department with rapidly progressive dyspnea that developed while climbing Mount Fuji. He had climbed Mount Fuji twice without experiencing similar symptoms. On arrival, his oxygen saturation was 91% on 10 L/min of oxygen with a non-rebreather mask. Chest imaging revealed scattered bilateral infiltrating shadows. He was diagnosed with high-altitude pulmonary edema (HAPE) and treated with high-dose corticosteroids, calcium-channel blockers, antibiotics, and oxygen via a high-flow nasal cannula. The patient responded to treatment and was discharged on day 7. Climbers should be aware of the risk of HAPE when climbing Mount Fuji.
一名51岁男性因在攀登富士山时出现快速进展的呼吸困难而被送往急诊科。他曾两次攀登富士山，均未出现类似症状。到达时，他使用非重复呼吸面罩，在吸氧流量为10升/分钟的情况下，血氧饱和度为91%。胸部影像学检查显示双侧散在浸润性阴影。他被诊断为高原肺水肿（HAPE），并接受了大剂量皮质类固醇、钙通道阻滞剂、抗生素治疗，同时通过高流量鼻导管吸氧。患者对治疗有反应，于第7天出院。登山者在攀登富士山时应意识到患HAPE的风险。
Zotero 插件